Skip to main content
Retour
Watch Compare

INTERPACE BIOSCIENCES, INC.

Qualité des données : 100%
IDXG
OTC Manufacturing Measuring & Analyzing Instruments
2,30 €
▲ 0,31 € (15,29%)
Cap. Boursière: 63,71 M
Prix
2,30 €
Cap. Boursière
63,71 M
Fourchette du Jour
2,00 € — 2,38 €
Fourchette 52 Semaines
0,44 € — 2,38 €
Volume
4 774
Ouverture 2,00 €
Moyenne 50J / 200J
1,78 €
29,57% above
Moyenne 50J / 200J
1,17 €
96,40% above

Quick Summary

Points Clés

Revenue declined -1,60% annually over 5 years
Earnings grew 266,68% over the past year
Net margin of 63,46% shows strong profitability
Generating 5,48 M in free cash flow
P/E of 2,59 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15,87%

Croissance

Revenue Growth (5Y)
-1,60%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-17,47%
Earnings (1Y)266,68%
FCF Growth (3Y)28,44%

Qualité

Return on Equity
N/A
ROIC72,43%
Net Margin63,46%
Op. Margin10,55%

Sécurité

Debt / Equity
N/A
Current Ratio1,54
Interest CoverageN/A

Valorisation

PE (TTM)
2,59
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDA13,66
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 2,6 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % 63,5 -41,5
Rev Growth 5Y % -1,6 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -17,47% Revenue Growth (3Y) -1,87%
Earnings Growth (1Y) 266,68% Earnings Growth (3Y) 453,55%
Revenue Growth (5Y) -1,60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 38,73 M Net Income (TTM) 24,58 M
ROE N/A ROA 201,67%
Gross Margin 62,31% Operating Margin 10,55%
Net Margin 63,46% Free Cash Flow (TTM) 5,48 M
ROIC 72,43% FCF Growth (3Y) 28,44%
Safety
Debt / Equity N/A Current Ratio 1,54
Interest Coverage N/A Asset Turnover 3,18
Working Capital 3,19 M Tangible Book Value -298 000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2,59 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 13,66 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 8,59%
Market Cap 63,71 M Enterprise Value 61,61 M
Per Share
EPS (Diluted TTM) 0,89 Revenue / Share 1,40
FCF / Share 0,20 OCF / Share 0,21
EPS CAGR (1Y) 122,50% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,92% FCF Conversion 22,28%
SBC-Adj. FCF 5,36 M Growth Momentum -15,87

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 38,73 M 46,93 M 40,21 M 5,68 M 41,31 M
Net Income 24,58 M 6,70 M 802 000,0 -21,96 M -14,94 M
EPS (Diluted) 0,89 0,40 0,18 — —
Gross Profit 24,13 M 29,93 M 23,90 M 18,23 M 17,95 M
Operating Income 4,08 M 8,11 M 2,80 M -3,62 M -14,00 M
EBITDA — — — — —
R&D Expenses 642 000,0 676 000,0 636 000,0 703 000,0 1,88 M
SG&A Expenses — — — — —
D&A 425 000,0 300 000,0 1,03 M 2,56 M 5,37 M
Interest Expense — -34 000,0 -112 000,0 -158 000,0 —
Income Tax -21,21 M 4 000,0 17 000,0 29 000,0 -667 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 33,84 M 14,79 M 13,02 M 15,98 M 38,43 M
Total Liabilities 11,48 M 17,01 M 28,16 M 32,52 M 34,31 M
Shareholders' Equity 22,36 M -2,22 M -61,67 M -63,07 M -42,42 M
Total Debt — — — — —
Cash & Equivalents 2,51 M 1,46 M 3,50 M 4,83 M 3,06 M
Current Assets 9,90 M 11,77 M 10,32 M 12,15 M 12,17 M
Current Liabilities 5,10 M 10,62 M 17,47 M 14,28 M 15,68 M